CDI Labs Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Pan-isotype Analysis Platform for serum antibody ...

TNXP READ THE FULL TNXP RESEARCH REPORT Financial Update On July 25, 2025, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ...

Studies suggest that people who had seasonal flus or vaccinations have low antibody levels against H5N1 bird flu.

GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonstrates ...

A new study has uncovered a distinct pattern of immune-related genes in hepatobiliary cancers, setting them apart from other gastrointestinal tumors.

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

The research highlights the potential of these immune proteins to enhance the effectiveness of checkpoint inhibitors in certain individuals.

A new dual vaccine for COVID-19 and flu shows strong immune responses and good safety in adults over 50, offering a potential one-shot alternative to separate vaccinations.

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the immune system, and immune cells produce a potentially lifesaving antibody ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.